Gene · 2810
Papers2,367
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,367
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reversible Dual-Covalent Molecular Locking of the 14-3-3/ERRγ Protein-Protein Interaction as a Molecular Glue Drug Discovery Approach. | J Am Chem Soc | 2023 | 36926879 | PubTator, text mining | PubMed |
| CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma. | Thorac Cancer | 2023 | 36924358 | PubTator, text mining | PubMed |
| Role of p53 in breast cancer progression: An insight into p53 targeted therapy. | Theranostics | 2023 | 36923534 | PubTator, text mining | PubMed |
| miRNome and Proteome Profiling of Human Keratinocytes and Adipose Derived Stem Cells Proposed miRNA-Mediated Regulations of Epidermal Growth Factor and Interleukin 1-Alpha. | Int J Mol Sci | 2023 | 36902387 | PubTator, text mining | PubMed |
| Epigenetic Abnormalities in Chondrosarcoma. | Int J Mol Sci | 2023 | 36901967 | PubTator, text mining | PubMed |
| Sulfotransferase 1C2 promotes hepatocellular carcinoma progression by enhancing glycolysis and fatty acid metabolism. | Cancer Med | 2023 | 36880364 | PubTator, text mining | PubMed |
| Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics. | Front Genet | 2023 | 36873929 | PubTator, text mining | PubMed |
| Targeting p53 pathways: mechanisms, structures, and advances in therapy. | Signal Transduct Target Ther | 2023 | 36859359 | PubTator, text mining | PubMed |
| J Subgroup Avian Leukosis Virus Strain Promotes Cell Proliferation by Negatively Regulating 14-3-3σ Expressions in Chicken Fibroblast Cells. | Viruses | 2023 | 36851618 | PubTator, text mining | PubMed |
| Comparison of PB1-F2 Proximity Interactomes Reveals Functional Differences between a Human and an Avian Influenza Virus. | Viruses | 2023 | 36851542 | PubTator, text mining | PubMed |
| Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers. | Int J Mol Sci | 2023 | 36834728 | PubTator, text mining | PubMed |
| Evidence and Metabolic Implications for a New Non-Canonical Role of Cu-Zn Superoxide Dismutase. | Int J Mol Sci | 2023 | 36834640 | PubTator, text mining | PubMed |
| Genetics, Treatment, and New Technologies of Hormone Receptor-Positive Breast Cancer. | Cancers (Basel) | 2023 | 36831644 | PubTator, text mining | PubMed |
| Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer. | Cells | 2023 | 36831341 | PubTator, text mining | PubMed |
| The p53 endoplasmic reticulum stress-response pathway evolved in humans but not in mice via PERK-regulated p53 mRNA structures. | Cell Death Differ | 2023 | 36813920 | PubTator, text mining | PubMed |
| [Retracted] Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma. | Int J Oncol | 2023 | 36799153 | PubTator, text mining | PubMed |
| A Pharmacological Review of Tanshinones, Naturally Occurring Monomers from Salvia miltiorrhiza for the Treatment of Cardiovascular Diseases. | Oxid Med Cell Longev | 2023 | 36793978 | PubTator, text mining | PubMed |
| Hippo signaling and histone methylation control cardiomyocyte cell cycle re-entry through distinct transcriptional pathways. | PLoS One | 2023 | 36780463 | PubTator, text mining | PubMed |
| ESRG is critical to maintain the cell survival and self-renewal/pluripotency of hPSCs by collaborating with MCM2 to suppress p53 pathway. | Int J Biol Sci | 2023 | 36778110 | PubTator, text mining | PubMed |
| Label-Free Proteomics of Oral Mucosa Tissue to Identify Potential Biomarkers That Can Flag Predilection of Precancerous Lesions to Oral Cell Carcinoma: A Preliminary Study. | Dis Markers | 2023 | 36776920 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2810/papers?page=9